Dr. Paul W Baker Jr., MD Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 600 Jessup Rd, Paulsboro, NJ 08066 Phone: 856-845-4061 Fax: 856-384-1770 |
Dr. Benjamin D Dijoseph Jr., DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Jessup Rd, Paulsboro, NJ 08066 Phone: 856-845-4061 Fax: 856-384-1770 |
News Archive
Chronic myeloid leukemia (CML) is a particular form of leukemia or cancer of the bone marrow, which can be treated with targeted imatinib. However, in some cases this medicine has no effect. Researchers at the VIB Vesalius Research Centre, K.U. Leuven, under the direction of Peter Carmeliet, have investigated the role of placental growth factor (PlGF) in mice with CML.
Isis Pharmaceuticals, Inc. announced today it has earned a $5 million milestone payment from Biogen Idec associated with the validation of an undisclosed target to treat a neurological disorder under its broad strategic collaboration with Biogen Idec to develop drugs to treat patients with neurological disorders.
Astellas Pharma Inc. and Potenza Therapeutics, Inc., a biotechnology company developing a portfolio of immuno-oncology programs, today announced an exclusive research and development collaboration.
The results of a new study on immune-based treatment of Alzheimer's disease (AD), which was conducted at 30 sites around the country, will be published in the December 15 issue of Neurology®. Lead author, Stephen P. Salloway, MD, MS, director of the Butler Hospital Memory and Aging Program and a professor of neurology and psychiatry at the Warren Alpert Medical School of Brown University, says that this 18-month phase two study on slowing the disease process in Alzheimer's patients offers promising results.
› Verified 9 days ago